Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA 4444-2 is a human non-coding RNA molecule from the microRNA family, implicated in post-transcriptional gene regulation. Elevated expression of miR-4444-2 is associated with poor prognosis in pancreatic adenocarcinoma, showing a correlation with increased proliferation and migration of pancreatic cancer cells. While miR-4444-2 has been used as part of a four-miRNA biomarker panel for risk stratification in pancreatic cancer, its precise molecular targets and broader functional roles remain to be experimentally validated. There is currently no evidence for direct therapeutic targeting or specific drug interactions with miR-4444-2[1][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 4444-2 (MIR4444-2).